Publication: Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
dc.contributor.author | Amin Gasmi | en_US |
dc.contributor.author | Sadaf Noor | en_US |
dc.contributor.author | Torsak Tippairote | en_US |
dc.contributor.author | Maryam Dadar | en_US |
dc.contributor.author | Alain Menzel | en_US |
dc.contributor.author | Geir Bjørklund | en_US |
dc.contributor.other | Council for Nutritional and Environmental Medicine | en_US |
dc.contributor.other | Razi Vaccine & Serum Research Institute, Iran | en_US |
dc.contributor.other | Laboratoires Reunis Kutter-Lieners-Hastert Centre Langwies | en_US |
dc.contributor.other | Bahauddin Zakariya University | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée | en_US |
dc.contributor.other | BBH Hospital | en_US |
dc.date.accessioned | 2020-06-02T04:42:55Z | |
dc.date.available | 2020-06-02T04:42:55Z | |
dc.date.issued | 2020-06-01 | en_US |
dc.description.abstract | © 2020 Elsevier Inc. It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II. | en_US |
dc.identifier.citation | Clinical Immunology. Vol.215, (2020) | en_US |
dc.identifier.doi | 10.1016/j.clim.2020.108409 | en_US |
dc.identifier.issn | 15217035 | en_US |
dc.identifier.issn | 15216616 | en_US |
dc.identifier.other | 2-s2.0-85084738239 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/56202 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084738239&origin=inward | en_US |
dc.subject | Immunology and Microbiology | en_US |
dc.subject | Medicine | en_US |
dc.title | Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic | en_US |
dc.type | Review | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084738239&origin=inward | en_US |